Biocon Limited
BIOCON
Rangering i aksjer
#3388
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Aksjekurs
$3.75
Sist synkronisert: 2026-10-19
Markedsverdi
$5.13B
Endring (1 dag)
-2.30%
Endring (1 år)
-9.49%
Land
IN
Handel Biocon Limited (BIOCON)
Kategori
Healthcare
P/S-forhold for Biocon Limited (BIOCON)
P/S-forhold per October 2026 TTM: 2.80
Ifølge Biocon Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 2.80. Ved slutten av 2024 hadde selskapet et P/S-forhold på 2.19.
P/S-historikk for Biocon Limited fra 2004 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.80 | 5.35% |
| 2025 | 2.66 | 21.75% |
| 2024 | 2.19 | -0.79% |
| 2023 | 2.20 | -54.89% |
| 2022 | 4.88 | -28.13% |
| 2021 | 6.80 | 33.65% |
| 2020 | 5.08 | -23.50% |
| 2019 | 6.65 | -22.37% |
| 2018 | 8.56 | 49.90% |
| 2017 | 5.71 | 101.52% |
| 2016 | 2.83 | -6.69% |
| 2015 | 3.04 | 12.72% |
| 2014 | 2.70 | 18.90% |
| 2013 | 2.27 | -0.79% |
| 2012 | 2.28 | -22.10% |
| 2011 | 2.93 | 7.96% |
| 2010 | 2.72 | 34.93% |
| 2009 | 2.01 | -59.64% |
| 2008 | 4.99 | -12.65% |
| 2007 | 5.71 | -7.76% |
| 2006 | 6.19 | 3.79% |
| 2005 | 5.97 | -26.97% |
| 2004 | 8.17 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 10.02 | 257.64% |
US
|
|
| 40.55 | 1,347.05% |
US
|
|
| 3.96 | 41.35% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | 262.07% |
NL
|
